Scope 1, 2, and 3 greenhouse gas (GHG) emissions
The company has an opportunity to reduce its scope 1, 2 and 3 greenhouse gas emissions, as well as report progress against these targets. Lastly, the company could align these emissions targets with a 1.5-degree trajectory.
Animal welfare
The company has an opportunity to set animal welfare targets applicable to all species, geographies and products.
Antibiotic use and growth promoting substances
While the company states that it upholds the veterinary drug use principle of “reduced use and no antibiotics”, it has an opportunity to disclose a policy on reducing the (prophylactic) use of antibiotics and/or growth promoting substances. It could also disclose targets to phase out their use across all species, geographies and products, and report progress against the targets.
Ecosystem conversion
While the company has a target to achieve conversion-free supply chains, it could report progress against it.
Food loss and waste
The company has a chance to declare its FLW reduction targets and track progress towards achieving these targets. Additionally, the company can align its FLW reduction goal with SDG12.3, which aims to achieve a 50% reduction by 2030.
Plastic use and packaging waste
While the company describes its activities to reduce plastic use and transition towards sustainable packaging, it has an opportunity to disclose the associated quantitative data.
Water withdrawal
The company has an opportunity to disclose a time-bound target for reducing water withdrawal in its own operations and to report on the progress made towards achieving this target. Additionally, it could report on the amount of water withdrawn for its operations in water-stressed areas. Moreover, the company can engage with suppliers in order to reduce water withdrawal collectively.